Wang X, Fan Z, Wang X, He Y, et al. Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study. Breast Cancer Res Treat 2022 Aug 2. pii: 10.1007/s10549-022-06686.
PMID: 35917052